Boothbay Fund Management LLC Purchases New Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Boothbay Fund Management LLC acquired a new stake in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 240 shares of the medical instruments supplier's stock, valued at approximately $294,000.

Other institutional investors have also recently modified their holdings of the company. Alliancebernstein L.P. lifted its position in Mettler-Toledo International by 9.9% during the fourth quarter. Alliancebernstein L.P. now owns 583,181 shares of the medical instruments supplier's stock worth $713,627,000 after purchasing an additional 52,726 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Mettler-Toledo International by 2.0% during the 4th quarter. Geode Capital Management LLC now owns 558,471 shares of the medical instruments supplier's stock worth $682,340,000 after acquiring an additional 11,032 shares during the period. Price T Rowe Associates Inc. MD boosted its position in shares of Mettler-Toledo International by 6.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 455,739 shares of the medical instruments supplier's stock worth $557,680,000 after acquiring an additional 25,873 shares in the last quarter. T. Rowe Price Investment Management Inc. raised its position in Mettler-Toledo International by 36.1% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 363,107 shares of the medical instruments supplier's stock valued at $444,327,000 after purchasing an additional 96,300 shares in the last quarter. Finally, Norges Bank bought a new stake in Mettler-Toledo International during the fourth quarter worth $372,954,000. 95.07% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, insider Christian Magloth sold 790 shares of Mettler-Toledo International stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the completion of the transaction, the insider now directly owns 734 shares of the company's stock, valued at approximately $964,248.46. This trade represents a 51.84 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Gerry Keller sold 600 shares of the firm's stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total value of $810,804.00. Following the sale, the insider now directly owns 6 shares of the company's stock, valued at $8,108.04. This represents a 99.01 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is owned by insiders.

Mettler-Toledo International Stock Up 4.5 %

Shares of NYSE:MTD opened at $1,103.95 on Friday. The firm has a market cap of $23.01 billion, a P/E ratio of 27.24, a P/E/G ratio of 3.30 and a beta of 1.28. Mettler-Toledo International Inc. has a 12-month low of $946.69 and a 12-month high of $1,546.93. The business has a fifty day simple moving average of $1,136.87 and a 200 day simple moving average of $1,233.56.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, topping analysts' consensus estimates of $7.90 by $0.29. The company had revenue of $883.74 million for the quarter, compared to analyst estimates of $876.61 million. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. The firm's quarterly revenue was down 4.6% on a year-over-year basis. During the same period in the previous year, the firm earned $8.89 earnings per share. As a group, equities research analysts expect that Mettler-Toledo International Inc. will post 42.71 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on MTD shares. Wells Fargo & Company dropped their price objective on Mettler-Toledo International from $1,400.00 to $1,125.00 and set an "equal weight" rating for the company in a research report on Thursday, April 17th. Robert W. Baird decreased their price target on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a report on Tuesday, April 22nd. Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price on the stock in a research report on Monday, April 7th. Finally, Evercore ISI increased their price target on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an "outperform" rating in a research note on Monday, February 10th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and four have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $1,304.25.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.